Skip to main content

Opaleye Management Inc.

13F filer · CIK 0001595855
Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$1.1BU.S. long equity reported on 13F
Positions5813 new · 8 closed
Net flow last quarter+$61.4MBuys minus sells
Top 10 positions weight64.8%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202658 positions
LQDALiquidia Corp$195M17.67%2.75%-3.8%Q1 2019
ETONEton Pharmaceuticals, Inc.$104M9.38%10.11%Not reportedQ4 2018
HROWHarrow, Inc.$102M9.23%6.40%-15.3%Q2 2020
IRONDisc Medicine, Inc.$62.5M5.66%2.23%+103.1%Q1 2025
URGNUroGen Pharma Ltd.$53M4.80%2.95%+0.7%Q2 2022
APGEApogee Therapeutics, Inc.$51.8M4.69%0.52%Not reportedQ3 2025
MGTXMeiraGTx Holdings plc$48M4.34%3.77%+67.2%Q3 2022
SLGLSol-Gel Technologies Ltd.$37.1M3.36%17.95%Not reportedQ3 2025
RZLTRezolute, Inc.$32.8M2.97%6.54%Not reportedQ3 2024
TGTXTG Therapeutics, Inc.$29.4M2.66%0.35%Not reportedQ3 2015
IMMXImmix Biopharma, Inc.$24.2M2.19%3.28%NewQ2 2026
CBIOCrescent Biopharma, Inc.$23.7M2.15%4.75%+0.5%Q4 2025
STOKStoke Therapeutics, Inc.$22.9M2.07%1.12%Not reportedQ4 2024
ACOGAlpha Cognition Inc.$20.9M1.89%13.30%+13.0%Q3 2025
EWTXEdgewise Therapeutics, Inc.$20.3M1.84%0.46%Not reportedQ1 2022
RVMDRevolution Medicines, Inc.$18.7M1.70%0.05%Not reportedQ2 2025
GLUEMonte Rosa Therapeutics, Inc.$18M1.63%0.87%NewQ2 2026
ALMSAlumis Inc.$15.5M1.40%Not reportedNot reportedQ2 2025
CDXSCodexis, Inc.$15.3M1.39%7.42%Not reportedQ1 2014
REPLReplimune Group, Inc.$15.3M1.39%1.65%NewQ2 2026
XOMAXOMA Royalty Corp$14.4M1.30%2.70%+12.8%Q2 2015
MBXMBX Biosciences, Inc.$14.4M1.30%0.54%Not reportedQ1 2025
RYTMRhythm Pharmaceuticals, Inc.$13.6M1.23%0.18%-0.4%Q4 2017
EDITEditas Medicine, Inc.$12.5M1.13%3.95%+100.4%Q1 2026
PTGXProtagonist Therapeutics, Inc$12.3M1.11%0.15%Not reportedQ4 2020
CABACabaletta Bio, Inc.$12M1.09%2.37%+180.0%Q3 2025
QTTBQ32 Bio Inc.$11.9M1.07%3.92%-25.9%Q4 2025
ANNXAnnexon, Inc.$9.79M0.89%1.15%-26.5%Q3 2025
VSTMVerastem, Inc.$6.88M0.62%1.99%Not reportedQ1 2020
ZNTLZentalis Pharmaceuticals, Inc.$6.85M0.62%1.97%Not reportedQ1 2024
RLMDRelmada Therapeutics, Inc.$6.47M0.59%0.88%Not reportedQ3 2023
OCULOcular Therapeutix, Inc$5.89M0.53%0.27%Not reportedQ2 2016
TRVITrevi Therapeutics, Inc.$5.78M0.52%0.22%-10.2%Q1 2023
BBOTBridgeBio Oncology Therapeutics, Inc.$5.33M0.48%0.87%+1213.8%Q1 2026
LYELLyell Immunopharma, Inc.$4.83M0.44%1.47%+334.9%Q1 2024
IRDOpus Genetics, Inc.$4.62M0.42%1.36%+0.5%Q1 2025
FDMT4D Molecular Therapeutics, Inc.$4.45M0.40%0.61%+197.8%Q4 2021
NTLAIntellia Therapeutics, Inc.$4.23M0.38%0.18%+2.0%Q2 2023
VYGRVoyager Therapeutics, Inc.$4.15M0.38%1.93%+3.0%Q4 2025
BDSXBiodesix Inc$4.06M0.37%1.71%-24.4%Q3 2023
RCKTRocket Pharmaceuticals, Inc.$3.42M0.31%0.91%+4.7%Q4 2025
JBIOJade Biosciences, Inc.$3.22M0.29%0.23%-66.1%Q4 2025
SNWVSANUWAVE Health, Inc.$3.06M0.28%3.56%-68.8%Q1 2025
FBIOFortress Biotech, Inc.$2.72M0.25%2.67%-14.6%Q1 2018
DERMJourney Medical Corp$2.48M0.22%3.03%-63.5%Q1 2022
PHATPhathom Pharmaceuticals, Inc.$2.01M0.18%0.23%Not reportedQ1 2023
INBXInhibrx Biosciences, Inc.$1.92M0.17%0.14%Not reportedQ2 2022
ENTAEnanta Pharmaceuticals Inc$1.82M0.17%0.43%Not reportedQ4 2016
COAGHemab Therapeutics Holdings, Inc.$1.75M0.16%0.10%NewQ2 2026
TRAXFirst Tracks Biotherapeutics, Inc.$1.31M0.12%0.18%NewQ2 2026
Q1 2026Reported May 15, 202653 positions
HROWHarrow, Inc.$99.9M13.15%7.60%-27.5%Q2 2020
LQDALiquidia Corp$88.8M11.70%2.88%+4.5%Q1 2019
ETONEton Pharmaceuticals, Inc.$70.6M9.30%10.45%Not reportedQ4 2018
SLGLSol-Gel Technologies Ltd.$39.6M5.22%17.95%+10.2%Q3 2025
RYTMRhythm Pharmaceuticals, Inc.$35.3M4.65%0.18%-62.7%Q4 2017
APGEApogee Therapeutics, Inc.$32.8M4.32%0.52%+0.5%Q3 2025
IRONDisc Medicine, Inc.$26.9M3.55%1.10%+110.5%Q1 2025
URGNUroGen Pharma Ltd.$25.7M3.39%2.94%+432.7%Q2 2022
CBIOCrescent Biopharma, Inc.$24.1M3.18%4.76%+11.4%Q4 2025
STOKStoke Therapeutics, Inc.$22.8M3.00%1.12%+0.7%Q4 2024
CATXPerspective Therapeutics, Inc.$19.5M2.57%4.10%+294.7%Q4 2025
RZLTRezolute, Inc.$19.2M2.53%6.54%+0.2%Q3 2024
MGTXMeiraGTx Holdings plc$18.4M2.42%2.61%+443.3%Q3 2022
TGTXTG Therapeutics, Inc.$17.8M2.34%0.35%Not reportedQ3 2015
SNWVSANUWAVE Health, Inc.$17M2.23%11.42%Not reportedQ1 2025
EWTXEdgewise Therapeutics, Inc.$15.8M2.07%0.47%Not reportedQ1 2022
ACOGAlpha Cognition Inc.$14.1M1.85%11.77%+23.7%Q3 2025
ANNXAnnexon, Inc.$12.9M1.70%1.56%-10.3%Q3 2025
ALMSAlumis Inc.$12.1M1.60%Not reported+2.8%Q2 2025
CDXSCodexis, Inc.$11.1M1.46%7.46%-0.1%Q1 2014
PTGXProtagonist Therapeutics, Inc$10.5M1.39%0.16%-4.8%Q4 2020
RVMDRevolution Medicines, Inc.$9.73M1.28%0.05%Not reportedQ2 2025
XOMAXOMA Royalty Corp$9.41M1.24%2.52%+2.5%Q2 2015
QTTBQ32 Bio Inc.$8.06M1.06%8.59%+488.8%Q4 2025
MBXMBX Biosciences, Inc.$7.76M1.02%0.55%Not reportedQ1 2025
RLMDRelmada Therapeutics, Inc.$6.51M0.86%0.89%Not reportedQ3 2023
CGONCG Oncology, Inc.$6.42M0.85%0.11%-76.9%Q1 2025
JBIOJade Biosciences, Inc.$6.01M0.79%0.87%Not reportedQ4 2025
OCULOcular Therapeutix, Inc$5.08M0.67%0.27%-62.4%Q2 2016
ASRTAssertio Holdings, Inc.$5.06M0.67%4.12%-6.8%Q4 2018
EDITEditas Medicine, Inc.$4.76M0.63%1.97%NewQ1 2026
STROSutro Biopharma, Inc.$4.75M0.63%1.15%Not reportedQ3 2020
DERMJourney Medical Corp$4.5M0.59%8.31%-1.5%Q1 2022
VYGRVoyager Therapeutics, Inc.$4.44M0.58%1.91%-3.9%Q4 2025
TRVITrevi Therapeutics, Inc.$4.12M0.54%0.27%Not reportedQ1 2023
TECXTectonic Therapeutic, Inc.$3.8M0.50%0.65%-42.7%Q4 2025
CABACabaletta Bio, Inc.$3.71M0.49%1.24%+53.3%Q3 2025
BDSXBiodesix Inc$3.45M0.45%2.36%Not reportedQ3 2023
RCKTRocket Pharmaceuticals, Inc.$3.42M0.45%0.88%Not reportedQ4 2025
ZNTLZentalis Pharmaceuticals, Inc.$3.31M0.44%1.99%+0.8%Q1 2024
NTLAIntellia Therapeutics, Inc.$3.14M0.41%0.20%Not reportedQ2 2023
FBIOFortress Biotech, Inc.$2.91M0.38%3.14%-4.4%Q1 2018
IRDOpus Genetics, Inc.$2.25M0.30%1.57%Not reportedQ1 2025
RIGLRigel Pharmaceuticals Inc$1.89M0.25%0.38%Not reportedQ3 2025
AVIRAtea Pharmaceuticals, Inc.$1.74M0.23%0.40%+79.4%Q4 2025
LYELLyell Immunopharma, Inc.$1.59M0.21%0.34%Not reportedQ1 2024
ENTAEnanta Pharmaceuticals Inc$1.58M0.21%0.43%+66.7%Q4 2016
NXTCNextCure, Inc.$1.51M0.20%3.91%Not reportedQ3 2019
FDMT4D Molecular Therapeutics, Inc.$1.05M0.14%0.21%Not reportedQ4 2021
PLXProtalix BioTherapeutics, Inc.$738K0.10%0.42%-86.3%Q4 2017
Q4 2025Reported Apr 13, 202654 positions
HROWHarrow, Inc.$191M25.25%10.49%Not reportedQ2 2020
LQDALiquidia Corp$85M11.21%2.79%-6.9%Q1 2019
ETONEton Pharmaceuticals, Inc.$48.4M6.38%10.57%Not reportedQ4 2018
RYTMRhythm Pharmaceuticals, Inc.$35.3M4.66%0.49%-28.5%Q4 2017
APGEApogee Therapeutics, Inc.$29.3M3.87%0.57%+6.9%Q3 2025
SNWVSANUWAVE Health, Inc.$29.3M3.86%11.42%+0.1%Q1 2025
STOKStoke Therapeutics, Inc.$22.1M2.91%1.18%+1.9%Q4 2024
OCULOcular Therapeutix, Inc$19.4M2.55%0.74%Not reportedQ2 2016
SLGLSol-Gel Technologies Ltd.$19.1M2.52%16.29%+121.5%Q3 2025
CGONCG Oncology, Inc.$17M2.25%0.51%Not reportedQ1 2025
TGTXTG Therapeutics, Inc.$15.9M2.10%0.34%Not reportedQ3 2015
IRONDisc Medicine, Inc.$15.9M2.10%0.53%+3.2%Q1 2025
RZLTRezolute, Inc.$14.8M1.96%6.58%+595.9%Q3 2024
CBIOCrescent Biopharma, Inc.$14M1.84%4.28%NewQ4 2025
ALKSAlkermes plc.$13.7M1.81%0.30%+8.9%Q3 2025
ACOGAlpha Cognition Inc.$13.5M1.78%9.52%+1698.5%Q3 2025
ANNXAnnexon, Inc.$13.1M1.72%1.74%Not reportedQ3 2025
EWTXEdgewise Therapeutics, Inc.$12.4M1.64%0.47%Not reportedQ1 2022
CDXSCodexis, Inc.$11.1M1.46%7.50%-46.9%Q1 2014
PTGXProtagonist Therapeutics, Inc$9.17M1.21%0.17%Not reportedQ4 2020
GOSSGossamer Bio, Inc.$8.43M1.11%1.16%-0.2%Q2 2023
MBXMBX Biosciences, Inc.$8.2M1.08%0.58%+2.8%Q1 2025
RVMDRevolution Medicines, Inc.$7.97M1.05%0.05%Not reportedQ2 2025
XOMAXOMA Royalty Corp$7.78M1.03%2.47%+14.7%Q2 2015
DERMJourney Medical Corp$7.52M0.99%8.44%+0.4%Q1 2022
KPTIKaryopharm Therapeutics Inc.$6.84M0.90%5.08%Not reportedQ2 2014
JBIOJade Biosciences, Inc.$6.6M0.87%0.87%NewQ4 2025
URGNUroGen Pharma Ltd.$6.29M0.83%0.56%Not reportedQ2 2022
ALMSAlumis Inc.$5.22M0.69%Not reported-19.6%Q2 2025
CATXPerspective Therapeutics, Inc.$4.99M0.66%1.59%NewQ4 2025
VYGRVoyager Therapeutics, Inc.$4.7M0.62%2.03%NewQ4 2025
RLMDRelmada Therapeutics, Inc.$4.52M0.60%1.28%Not reportedQ3 2023
TECXTectonic Therapeutic, Inc.$4.48M0.59%1.15%NewQ4 2025
PLXProtalix BioTherapeutics, Inc.$4.46M0.59%3.08%-4.0%Q4 2017
TRVITrevi Therapeutics, Inc.$4.32M0.57%0.27%-11.5%Q1 2023
FBIOFortress Biotech, Inc.$3.99M0.53%3.48%Not reportedQ1 2018
RCKTRocket Pharmaceuticals, Inc.$3.35M0.44%0.88%NewQ4 2025
MGTXMeiraGTx Holdings plc$3.11M0.41%0.48%Not reportedQ3 2022
RIGLRigel Pharmaceuticals Inc$3M0.40%0.38%+85.3%Q3 2025
ZYMEZymeworks Inc.$2.87M0.38%0.15%+8.9%Q4 2018
ASRTAssertio Holdings, Inc.$2.58M0.34%4.44%Not reportedQ4 2018
VTYXVentyx Biosciences, Inc.$2.27M0.30%0.35%Not reportedQ4 2023
IRDOpus Genetics, Inc.$2.25M0.30%1.60%+1.8%Q1 2025
STROSutro Biopharma, Inc.$2.21M0.29%2.22%Not reportedQ3 2020
CABACabaletta Bio, Inc.$1.97M0.26%0.90%+11.3%Q3 2025
ZNTLZentalis Pharmaceuticals, Inc.$1.89M0.25%2.03%+342.6%Q1 2024
GBIOGeneration Bio Co.$1.76M0.23%4.60%NewQ4 2025
BBIOBridgeBio Pharma, Inc.$1.4M0.18%0.01%Not reportedQ1 2021
ENTAEnanta Pharmaceuticals Inc$1.18M0.16%0.26%Not reportedQ4 2016
QTTBQ32 Bio Inc.$708K0.09%1.66%NewQ4 2025
Q3 2025Reported Nov 14, 202542 positions
HROWHarrow, Inc.$188M26.60%10.54%Not reportedQ2 2020
ETONEton Pharmaceuticals, Inc.$62.1M8.79%10.66%Not reportedQ4 2018
LQDALiquidia Corp$59.5M8.41%3.01%+5.7%Q1 2019
RYTMRhythm Pharmaceuticals, Inc.$46.6M6.59%0.69%-2.8%Q4 2017
IMNMImmunome Inc.$37.3M5.27%3.47%-9.8%Q2 2024
SNWVSANUWAVE Health, Inc.$36.7M5.19%11.43%Not reportedQ1 2025
CDXSCodexis, Inc.$31.2M4.41%14.17%+1.6%Q1 2014
TGTXTG Therapeutics, Inc.$19.3M2.73%0.34%Not reportedQ3 2015
OCULOcular Therapeutix, Inc$18.6M2.64%0.91%Not reportedQ2 2016
CGONCG Oncology, Inc.$16.5M2.33%0.52%+54.1%Q1 2025
STOKStoke Therapeutics, Inc.$16M2.27%1.24%+21.3%Q4 2024
APGEApogee Therapeutics, Inc.$14.4M2.04%0.61%NewQ3 2025
ALKSAlkermes plc.$13.5M1.91%0.27%NewQ3 2025
IRONDisc Medicine, Inc.$12.8M1.81%0.55%+4.0%Q1 2025
SRPTSarepta Therapeutics, Inc.$11.3M1.59%0.56%+17.0%Q2 2025
LRMRLarimar Therapeutics, Inc.$10.6M1.49%4.35%-9.5%Q2 2021
XOMAXOMA Royalty Corp$9.83M1.39%2.07%Not reportedQ2 2015
RZLTRezolute, Inc.$8.49M1.20%0.99%Not reportedQ3 2024
ARVNArvinas, Inc.$8.42M1.19%1.40%-41.2%Q2 2019
EWTXEdgewise Therapeutics, Inc.$8.11M1.15%0.47%+2.0%Q1 2022
ANNXAnnexon, Inc.$7.93M1.12%2.38%NewQ3 2025
GOSSGossamer Bio, Inc.$7.17M1.01%1.18%-23.1%Q2 2023
PTGXProtagonist Therapeutics, Inc$6.98M0.99%0.17%Not reportedQ4 2020
DERMJourney Medical Corp$6.91M0.98%8.40%+922.2%Q1 2022
SLGLSol-Gel Technologies Ltd.$5.97M0.84%7.35%NewQ3 2025
PLXProtalix BioTherapeutics, Inc.$5.73M0.81%3.24%Not reportedQ4 2017
TMCITreace Medical Concepts, Inc.$4.71M0.67%1.11%NewQ3 2025
RVMDRevolution Medicines, Inc.$4.67M0.66%0.05%-4.8%Q2 2025
MBXMBX Biosciences, Inc.$4.43M0.63%0.57%+5.7%Q1 2025
TRVITrevi Therapeutics, Inc.$3.57M0.50%0.30%Not reportedQ1 2023
ADCTADC Therapeutics SA$2.73M0.39%0.61%NewQ3 2025
ALMSAlumis Inc.$2.65M0.38%Not reported-14.2%Q2 2025
CABACabaletta Bio, Inc.$1.89M0.27%0.84%NewQ3 2025
IRDOpus Genetics, Inc.$1.82M0.26%1.70%-9.8%Q1 2025
ZYMEZymeworks Inc.$1.71M0.24%0.13%-52.4%Q4 2018
SYRESpyre Therapeutics, Inc.$1.09M0.15%0.11%NewQ3 2025
RIGLRigel Pharmaceuticals Inc$1.07M0.15%0.21%NewQ3 2025
ACOGAlpha Cognition Inc.$750K0.11%0.71%NewQ3 2025
ZNTLZentalis Pharmaceuticals, Inc.$478K0.07%0.44%-83.6%Q1 2024
PEPGPepGen Inc.$347K0.05%0.23%-68.8%Q3 2024
IBIOiBio, Inc.$310K0.04%1.85%Not reportedQ1 2024
ADGMAdagio Medical Holdings, Inc.$215K0.03%0.72%Not reportedQ3 2024
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.